evogliptin
DA1229_DMC_III
Phase 3 small_molecule completed
Quick answer
evogliptin for Type 2 Diabetes Mellitus is a Phase 3 program (small_molecule) at Dong Wang with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Dong Wang
- Indication
- Type 2 Diabetes Mellitus
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed